Citation Tools

Download PDFPDF

Clinical sciences oral session 5—treatment: Syphilis, Herpes, &
O3-S5.01 Impact of AIC316, a novel antiviral helicase-primase inhibitor, on genital HSV shedding: randomised, double-blind, placebo-controlled trial
Free

Download to a citation manager

Cite this article as:
Wald A, Stoelben S, Tyring S, et al
O3-S5.01 Impact of AIC316, a novel antiviral helicase-primase inhibitor, on genital HSV shedding: randomised, double-blind, placebo-controlled trial